• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无γ-羧基谷氨酸结构域的活化蛋白C的2.8埃晶体结构。

The 2.8 A crystal structure of Gla-domainless activated protein C.

作者信息

Mather T, Oganessyan V, Hof P, Huber R, Foundling S, Esmon C, Bode W

机构信息

Abteilung Strukturforschung, Max Planck Institut für Biochemie, Martinsried, Germany.

出版信息

EMBO J. 1996 Dec 16;15(24):6822-31.

PMID:9003757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC452507/
Abstract

The structure of the Gla-domainless form of the human anticoagulant enzyme activated protein C has been solved at 2.8 A resolution. The light chain is composed of two domains: an epidermal growth factor (EGF)-like domain modified by a large insert containing an additional disulfide, followed by a typical EGF-like domain. The arrangement of the long axis of these domains describes an angle of approximately 80 degrees. Disulfide linked to the light chain is the catalytic domain, which is generally trypsin-like but contains a large insertion loop at the edge of the active site, a third helical segment, a prominent cationic patch analogous to the anion binding exosite I of thrombin and a trypsin-like Ca[II] binding site. The arrangement of loops around the active site partially restricts access to the cleft. The S2 and S4 subsites are much more polar than in factor Xa and thrombin, and the S2 site is unrestricted. While quite open and exposed, the active site contains a prominent groove, the surface of which is very polar with evidence for binding sites on the primed side, in addition to those typical of the trypsin class found on the non-primed side.

摘要

人抗凝酶活化蛋白C无γ-羧基谷氨酸(Gla)结构域形式的结构已在2.8埃分辨率下解析出来。轻链由两个结构域组成:一个表皮生长因子(EGF)样结构域,被一个含有额外二硫键的大插入片段修饰,接着是一个典型的EGF样结构域。这些结构域长轴的排列形成约80度的夹角。与轻链相连的二硫键部分是催化结构域,其总体上类似胰蛋白酶,但在活性位点边缘含有一个大的插入环、一个第三螺旋片段、一个类似于凝血酶阴离子结合外位点I的突出阳离子斑块以及一个胰蛋白酶样的Ca[II]结合位点。活性位点周围环的排列部分限制了对裂隙的 access。S2和S4亚位点比因子Xa和凝血酶中的极性大得多,且S2位点无限制。虽然活性位点相当开放且暴露,但它含有一个突出的凹槽,其表面极性很强,除了在非引发侧发现的那些典型的胰蛋白酶类结合位点外,在引发侧也有结合位点的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/452507/3aecd9930bb3/emboj00024-0058-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/452507/702fe31c5bc4/emboj00024-0053-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/452507/c0977affd0b9/emboj00024-0054-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/452507/6cc0c72a7a71/emboj00024-0055-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/452507/8943474a1952/emboj00024-0056-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/452507/b0d901b68e28/emboj00024-0056-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/452507/3aecd9930bb3/emboj00024-0058-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/452507/702fe31c5bc4/emboj00024-0053-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/452507/c0977affd0b9/emboj00024-0054-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/452507/6cc0c72a7a71/emboj00024-0055-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/452507/8943474a1952/emboj00024-0056-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/452507/b0d901b68e28/emboj00024-0056-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/452507/3aecd9930bb3/emboj00024-0058-a.jpg

相似文献

1
The 2.8 A crystal structure of Gla-domainless activated protein C.无γ-羧基谷氨酸结构域的活化蛋白C的2.8埃晶体结构。
EMBO J. 1996 Dec 16;15(24):6822-31.
2
Structure of human des(1-45) factor Xa at 2.2 A resolution.人去(1-45)因子Xa在2.2埃分辨率下的结构。
J Mol Biol. 1993 Aug 5;232(3):947-66. doi: 10.1006/jmbi.1993.1441.
3
The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.重组双链人组织型纤溶酶原激活剂催化结构域的2.3埃晶体结构。
J Mol Biol. 1996 Apr 26;258(1):117-35. doi: 10.1006/jmbi.1996.0238.
4
Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).活性位点抑制的人凝血因子VIIa(去γ-羧基谷氨酸)的晶体结构
J Struct Biol. 1999 Oct;127(3):213-23. doi: 10.1006/jsbi.1999.4158.
5
Active and exo-site inhibition of human factor Xa: structure of des-Gla factor Xa inhibited by NAP5, a potent nematode anticoagulant protein from Ancylostoma caninum.人凝血因子Xa的活性位点和外位点抑制:犬钩口线虫的一种强效线虫抗凝血蛋白NAP5抑制的去γ-羧基凝血因子Xa的结构
J Mol Biol. 2007 Aug 17;371(3):774-86. doi: 10.1016/j.jmb.2007.05.042. Epub 2007 May 18.
6
Contributions of Gla and EGF-like domains to the function of vitamin K-dependent coagulation factors.γ-羧基谷氨酸(Gla)和表皮生长因子(EGF)样结构域对维生素K依赖性凝血因子功能的贡献。
Crit Rev Eukaryot Gene Expr. 1999;9(1):59-88.
7
Crystal structure of coagulation factor IX-binding protein from habu snake venom at 2.6 A: implication of central loop swapping based on deletion in the linker region.矛头蝮蛇毒中凝血因子IX结合蛋白在2.6埃分辨率下的晶体结构:基于连接区缺失对中心环交换的启示
J Mol Biol. 1999 May 28;289(1):103-12. doi: 10.1006/jmbi.1999.2756.
8
Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex.凝血酶-血栓调节蛋白复合物抗凝活性的结构基础。
Nature. 2000 Mar 30;404(6777):518-25. doi: 10.1038/35006683.
9
Energetics of thrombin-thrombomodulin interaction.凝血酶-血栓调节蛋白相互作用的能量学
Biochemistry. 1997 Jun 3;36(22):6674-81. doi: 10.1021/bi962766a.
10
The crystal structure of Helicobacter cysteine-rich protein C at 2.0 A resolution: similar peptide-binding sites in TPR and SEL1-like repeat proteins.幽门螺杆菌富含半胱氨酸蛋白C在2.0埃分辨率下的晶体结构:TPR和SEL1样重复蛋白中相似的肽结合位点
J Mol Biol. 2004 Jul 16;340(4):829-41. doi: 10.1016/j.jmb.2004.04.055.

引用本文的文献

1
Cryo-EM structure of coagulation factor Va bound to activated protein C.与活化蛋白C结合的凝血因子Va的冷冻电镜结构
Blood. 2025 Jun 26;145(26):3166-3177. doi: 10.1182/blood.2025028476.
2
The novel protein C variant p.C101F results in early intracellular degradation that drives type I protein C deficiency.新型蛋白C变体p.C101F导致早期细胞内降解,从而引发I型蛋白C缺乏症。
Int J Hematol. 2025 Jun;121(6):774-781. doi: 10.1007/s12185-025-03943-z. Epub 2025 Feb 10.
3
Unraveling the Molecular Pathogenesis of Protein C Deficiency-Associated VTE: Insights from Protein C Mutations C238G and R189W in Thai Patients.

本文引用的文献

1
Activation of purified prothrombin to autoprothrombin I or autoprothrombin II (platelet cofactor II or autoprothrombin II-A).将纯化的凝血酶原激活为自凝血酶原I或自凝血酶原II(血小板辅因子II或自凝血酶原II-A)。
Thromb Diath Haemorrh. 1960 Dec 15;5:218-49.
2
Protein C activation.蛋白C激活
Methods Enzymol. 1993;222:359-85. doi: 10.1016/0076-6879(93)22024-a.
3
Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C.凝血因子Va与活化蛋白C 311-325位残基的相互作用及抑制作用
解析蛋白C缺乏相关静脉血栓形成的分子发病机制:来自泰国患者蛋白C突变C238G和R189W的见解
Thromb Haemost. 2025 Jun;125(6):533-544. doi: 10.1055/a-2408-9529. Epub 2024 Sep 3.
4
Quality Assessment of Selected Protein Structures Derived from Homology Modeling and AlphaFold.源自同源建模和AlphaFold的选定蛋白质结构的质量评估
Pharmaceuticals (Basel). 2023 Nov 29;16(12):1662. doi: 10.3390/ph16121662.
5
Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study.中国人群中两种PROC热点突变(Arg189Trp和Lys193del)的血栓形成前风险评估:一项回顾性研究。
Thromb J. 2023 Oct 3;21(1):103. doi: 10.1186/s12959-023-00548-6.
6
Fluorescent Activity-Based Probe To Image and Inhibit Factor XIa Activity in Human Plasma.用于在人血浆中成像和抑制因子 XIa 活性的荧光活性探针。
J Med Chem. 2023 Mar 23;66(6):3785-3797. doi: 10.1021/acs.jmedchem.2c00845. Epub 2023 Mar 10.
7
Comparative sequence analysis of vitamin K-dependent coagulation factors.维生素 K 依赖性凝血因子的比较序列分析。
J Thromb Haemost. 2022 Dec;20(12):2837-2849. doi: 10.1111/jth.15897. Epub 2022 Oct 11.
8
Parallel imaging of coagulation pathway proteases activated protein C, thrombin, and factor Xa in human plasma.人血浆中凝血途径蛋白酶活化蛋白C、凝血酶和因子Xa的并行成像
Chem Sci. 2022 Apr 27;13(23):6813-6829. doi: 10.1039/d2sc01108e. eCollection 2022 Jun 15.
9
Cleavage-Responsive Biofactory T Cells Suppress Infectious Diseases-Associated Hypercytokinemia.可裂解型生物工厂 T 细胞抑制感染性疾病相关的细胞因子血症。
Adv Sci (Weinh). 2022 Sep;9(26):e2201883. doi: 10.1002/advs.202201883. Epub 2022 Jun 25.
10
The active site region plays a critical role in Na binding to thrombin.活性位点区域在钠离子与凝血酶的结合中起着关键作用。
J Biol Chem. 2022 Jan;298(1):101458. doi: 10.1016/j.jbc.2021.101458. Epub 2021 Nov 30.
Protein Sci. 1993 Sep;2(9):1482-9. doi: 10.1002/pro.5560020912.
4
Structure of human des(1-45) factor Xa at 2.2 A resolution.人去(1-45)因子Xa在2.2埃分辨率下的结构。
J Mol Biol. 1993 Aug 5;232(3):947-66. doi: 10.1006/jmbi.1993.1441.
5
SETOR: hardware-lighted three-dimensional solid model representations of macromolecules.SETOR:大分子的硬件照明三维实体模型表示
J Mol Graph. 1993 Jun;11(2):134-8, 127-8. doi: 10.1016/0263-7855(93)87009-t.
6
A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va.人活化蛋白C轻链中一个与凝血因子Va相互作用所必需的新型外部位点。
Biochemistry. 1993 Nov 30;32(47):12656-63. doi: 10.1021/bi00210a014.
7
Interaction of activated protein C with serpins.活化蛋白C与丝氨酸蛋白酶抑制剂的相互作用。
Biochem J. 1993 Oct 1;295 ( Pt 1)(Pt 1):239-45. doi: 10.1042/bj2950239.
8
Mutation in blood coagulation factor V associated with resistance to activated protein C.凝血因子V突变与活化蛋白C抵抗相关。
Nature. 1994 May 5;369(6475):64-7. doi: 10.1038/369064a0.
9
Resistance to inhibition by alpha-1-anti-trypsin and species specificity of a chimeric human/bovine protein C.α-1-抗胰蛋白酶抑制作用的抗性及人/牛嵌合蛋白C的物种特异性
Biochemistry. 1994 Feb 22;33(7):1876-80. doi: 10.1021/bi00173a034.
10
Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors.活化蛋白C中谷氨酸192向谷氨酰胺的转化改变了底物特异性,并增加了对大分子抑制剂的反应性。
J Biol Chem. 1993 Sep 25;268(27):19943-8.